Stride Velocity 95th Centile: Insights into Gaining Regulatory Qualification of the First Wearable-Derived Digital Endpoint for use in Duchenne Muscular Dystrophy Trials. (2022)
Attributed to:
Oxford P2D: From Technologies to Therapies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3233/jnd-210743
PubMed Identifier: 34958044
Publication URI: http://europepmc.org/abstract/MED/34958044
Type: Journal Article/Review
Volume: 9
Parent Publication: Journal of neuromuscular diseases
Issue: 2
ISSN: 2214-3599